Literature DB >> 26634709

Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.

A Rodríguez-García1, S González-Godínez2, S López-Rubio2.   

Abstract

PURPOSE: The main objective of this study is to describe the prevalence, degree and risk of corneal involvement, and visual impact in a pediatric population with blepharokeratoconjunctivitis (BKC).
METHODS: Retrospective, observational, case-control study. Clinical records of patients ≤16 years old with BKC seen between 2006 and 2012 were reviewed. The prevalence and relative risk of corneal involvement was evaluated between patients with and without corneal affection through a univariate and multivariate analysis with logistic regression. Visual acuity at presentation and at last follow-up visit was also analyzed.
RESULTS: One hundred and fourteen children with BKC, with a male-to-female ratio of 1 : 1 and a mean age at diagnosis of 9.13 years. The mean follow-up time was 26.4 (±25) months. Corneal involvement was present in 39.5% of patients, varying from superficial punctate keratitis to perforation. Corneal changes were not seen in children under 4 years old. The risk of corneal affection was greater in patients with photophobia, hordeolum, female gender and asymmetric disease (OR of 2.69, 11.6, 2.35 and 2.77, respectively). The mean best-corrected visual acuity at presentation was 0.20 (corneal affected group), compared to 0.11 (unaffected group; P=0.02).
CONCLUSIONS: Our study showed an older age at time of diagnosis and a worse visual outcome in patients with BKC and corneal disease compared with previous reports. Early diagnosis and detection of risk factors for corneal involvement, as well as adequate treatment, is mandatory to prevent serious long-term visual repercussions in children with BKC.

Entities:  

Mesh:

Year:  2015        PMID: 26634709      PMCID: PMC4791702          DOI: 10.1038/eye.2015.249

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  35 in total

1.  Oral erythromycin treatment for childhood blepharokeratitis.

Authors:  D M Meisler; M B Raizman; E I Traboulsi
Journal:  J AAPOS       Date:  2000-12       Impact factor: 1.220

2.  Improvement of tear stability following warm compression in patients with meibomian gland dysfunction.

Authors:  Eiki Goto; Koji Endo; Atsushi Suzuki; Yoshiaki Fujikura; Kazuo Tsubota
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

3.  Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjögren's syndrome.

Authors:  B D Sullivan; J M Cermak; R M Sullivan; A S Papas; J E Evans; M R Dana; D A Sullivan
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

4.  Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction.

Authors:  Mary Catherine Olson; Donald R Korb; Jack V Greiner
Journal:  Eye Contact Lens       Date:  2003-04       Impact factor: 2.018

5.  The influence of eyelid temperature on the delivery of meibomian oil.

Authors:  Attila Nagymihályi; Shabtay Dikstein; John M Tiffany
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

6.  Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics.

Authors:  Altuğ Cetinkaya; Yonca Aydin Akova
Journal:  Am J Ophthalmol       Date:  2006-11       Impact factor: 5.258

7.  Long-term visual outcome of childhood blepharokeratoconjunctivitis.

Authors:  Serge Doan; Eric E Gabison; Sylvia Nghiem-Buffet; Olivia Abitbol; Damien Gatinel; Thanh Hoang-Xuan
Journal:  Am J Ophthalmol       Date:  2006-11-09       Impact factor: 5.258

8.  [Improvement of dry eye symptoms with polyunsaturated fatty acids].

Authors:  C Creuzot; M Passemard; S Viau; C Joffre; P Pouliquen; P P Elena; A Bron; F Brignole
Journal:  J Fr Ophtalmol       Date:  2006-10       Impact factor: 0.818

9.  Ocular rosacea in childhood.

Authors:  Sayeda Asad Nazir; Scott Murphy; R Michael Siatkowski; James Chodosh; Rhea L Siatkowski
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

10.  Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.

Authors:  Antonio Pinna; Paola Piccinini; Francesco Carta
Journal:  Cornea       Date:  2007-04       Impact factor: 2.651

View more
  5 in total

Review 1.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

2.  Safety and Feasibility of Low Fluence Intense Pulsed Light for Treating Pediatric Patients with Moderate-to-Severe Blepharitis.

Authors:  Zimeng Zhai; Hao Jiang; Yuqing Wu; Pei Yang; Shuyun Zhou; Jiaxu Hong
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

3.  Evaluation of the ocular surface characteristics and Demodex infestation in paediatric and adult blepharokeratoconjunctivitis.

Authors:  Mengliang Wu; Xiaochun Wang; Jing Han; Tingting Shao; Yan Wang
Journal:  BMC Ophthalmol       Date:  2019-03-07       Impact factor: 2.209

Review 4.  Topical Steroids and Antibiotics for Adult Blepharokeratoconjunctivitis (BKC): A Meta-Analysis of Randomized Clinical Trials.

Authors:  Lu Zhao; Ya-Jie Sun; Zhi-Qiang Pan
Journal:  J Ophthalmol       Date:  2021-01-08       Impact factor: 1.909

5.  Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children.

Authors:  Chu Luan Nguyen; Tony S Chen; Khoi Tran; James E H Smith; Noni Lewis
Journal:  Case Rep Ophthalmol Med       Date:  2018-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.